NOVAVAX INC Derivative Liability, Current
NOVAVAX INC (NVAX) had Derivative Liability, Current of $267.00 thousand as of 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2014-03-12
- 2013-03-31: Derivative Liability, Current $267.00K.
- 2012-12-31: Derivative Liability, Current $267.00K.
- 2012-09-30: Derivative Liability, Current $769.00K.
| Period end | Derivative Liability, Current |
|---|---|
| 2013-03-31 | $267.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $267.00K 10-K · filed 2014-03-12 |
| 2012-09-30 | $769.00K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |